Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05592132 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Virtual Reality in Pain Management in Pediatric Oncology

Study acronym: DOREVI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later May 2026 → Dec 2026
See other at-risk trials from Centre Hospitalier Universitaire de la Réunion

Record History

  1. Primary and study completion pushed from May 2026 to Dec 2026v4
  2. Primary and study completion dates: Oct 2025 to May 2026v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Dec 2022 to Oct 2025
    • Study sites: 0 to 1
    • Study completion date: Mar 2025 to Oct 2025
    • Start date changed from estimate of Nov 2022 to Jan 17, 2023
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.
Trial Details
NCT Number NCT05592132
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions
(from sponsor)		 Pediatric Tumor
Related terms Neoplasms
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov